Oncodesign Company
![](/files/companies/Oncodesign(COM)%20.jpg)
Oncodesign develops anticancer therapies for the treatment of patients with cancer.
Headquarters:
Others
Industry:
P4 Medicine
Employee Number:
101-250
Estimated Revenue:
$1M to $10M
Investors Number:
3
Investor Type:
For Profit
Funding Status:
IPO
Technology:
Precision Medicine
Last Funding Type:
Venture - Series Unknown
Founded Date:
1995-01-01
Total Funding:
$29.4M